home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post navigation
Previous Post
Previous
Cullinan Oncology to Participate in Upcoming Investor Conferences
Next Post
Next
Revolution Medicines to Report Financial Results for Third Quarter 2022 After Market Close on November 7, 2022